Zhaoke Ophthalmology Limited (HKG:6622)

Hong Kong · Delayed Price · Currency is HKD

3.000

+0.100 (3.45%)

May 7, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Development, Manufacturing and Marketing of Ophthalmic Drugs	31.97M	69.32M	18.75M	-	-
Development, Manufacturing and Marketing of Ophthalmic Drugs Growth	-53.88%	269.73%	-	-	-
Total	31.97M	69.32M	18.75M	-	-
Total Growth	-53.88%	269.73%	-	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Hong Kong	614.00K	803.00K	769.00K	-	-
Hong Kong Growth	-23.54%	4.42%	-	-	-
Mainland China	29.85M	67.32M	12.38M	-	-
Mainland China Growth	-55.66%	443.71%	-	-	-
South Korea	1.09M	1.19M	5.60M	-	-
South Korea Growth	-8.88%	-78.68%	-	-	-
Others	424.00K	10.00K	-	-	-
Others Growth	4140.00%	-	-	-	-
Total	31.97M	69.32M	18.75M	-	-
Total Growth	-53.88%	269.73%	-	-	-

Source: S&P Global Market Intelligence.